- Lobbying
- Lobbying by Isis Pharmaceuticals
Lobbying Relationship
Bills mentioned
S.23: America Invents Act
Sponsor: Patrick J. Leahy (D-Vt.)
H.R.1249: Leahy-Smith America Invents Act
Sponsor: Lamar Smith (R-Texas)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Stephen M. Ryan | 1987-91: Gen Counsel, Govt Affairs Comm, US Senate; 1986: Asst US Attorney, DC; 1984-86: Deputy Counsel, President's Commission on Organized Crime. US Senate; 1986: Asst US Attorney, DC; 1984-86: Deputy Counsel, President's Commission on |
David Ransom | 2007-08: Sr Communications and Policy Advisor, House Majority Leader Steny Hoyer; 2002-06: Communications Director, House Democratic Whip Steny Hoyer; 1999-2001: Communications Director, House Committee on Administration (Steny Hoyer, Ranking Member). Organized Crime. Advisor, House Majority Leader Steny Hoyer; 2002-06: Communications Director, House Communiations Director, House Committee on Administration (Steny Hoyer, Ranking |
Sheila D. Walcoff | 2006-07: Counselor to The Honorable Michael O. Leavitt (Immediate Office of the Secretary), U.S. Commissioner for External Relations, U.S. FDA; 1998-99: Majority Counsel, Armed Services Committee, U.S. House of Representatives. 1987-91: Gen Counsel, Govt Affairs Comm US Senate; 1986: Asst US Attorney, DC. Michael O. Leavitt (Immediate Office of the Secretary), 2004-06: Associate Commissioner for External Relations, U.S. FDA; 1998-99: Majority Counsel, 2006-07: Counselor to The Honorable |
David Ramsom | Member) |
Sheila Walcoff | 2006-07: Counselor to The Honorable |
Karen Sealander | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. Senate
Medical
Pharmacy
U.S. Senate
Medical
Pharmacy
U.S. Senate
Medical
Pharmacy
U.S. Senate
Medical
Pharmacy
U.S. Senate
Medical
Pharmacy
U.S. Senate
Medical
Pharmacy
U.S. Senate
Medical
Pharmacy
U.S. Senate
U.S. Senate
Pharmacy
U.S. Senate
Medical
Pharmacy
U.S. Senate
Medical
Pharmacy
U.S. Senate
Medical
Pharmacy
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate